• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(原)肾素受体:十年研究,成果几何?

The (pro)renin receptor. A decade of research: what have we learned?

机构信息

Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands.

出版信息

Pflugers Arch. 2013 Jan;465(1):87-97. doi: 10.1007/s00424-012-1105-z. Epub 2012 Apr 28.

DOI:10.1007/s00424-012-1105-z
PMID:22543358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3553411/
Abstract

The discovery of a (pro)renin receptor ((P)RR) in 2002 provided a long-sought explanation for tissue renin-angiotensin system (RAS) activity and a function for circulating prorenin, the inactive precursor of renin, in end-organ damage. Binding of renin and prorenin (referred to as (pro)renin) to the (P)RR increases angiotensin I formation and induces intracellular signalling, resulting in the production of profibrotic factors. However, the (pro)renin concentrations required for intracellular signalling in vitro are several orders of magnitude above (patho)physiological plasma levels. Moreover, the phenotype of prorenin-overexpressing animals could be completely attributed to angiotensin generation, possibly even without the need for a receptor. The efficacy of the only available putative (pro)renin receptor blocker handle region peptide remains doubtful, leading to inconclusive results. The fact that, in contrast to other RAS components, (P)RR knock-outs, even tissue-specific, are lethal, points to an important, (pro)renin-independent, function of the (P)RR. Indeed, recent research has highlighted ancillary functions of the (P)RR as an essential accessory protein of the vacuolar-type H(+)-ATPase (V-ATPase), and in this role, it acts as an intermediate in Wnt signalling independent of (pro)renin. In conclusion, (pro)renin-dependent signalling is unlikely in non-(pro)renin synthesizing organs, and the (P)RR role in V-ATPase integrity and Wnt signalling may explain some, if not all of the phenotypes previously associated with (pro)renin-(P)RR interaction.

摘要

2002 年发现的(前)肾素受体((P)RR)为组织肾素-血管紧张素系统(RAS)活性提供了长期寻求的解释,并为循环前肾素(肾素的无活性前体)在靶器官损伤中的作用提供了解释。肾素和前肾素((前)肾素)与(P)RR 的结合增加了血管紧张素 I 的形成并诱导细胞内信号转导,导致产生促纤维化因子。然而,体外细胞内信号转导所需的(前)肾素浓度要高出(病理)生理血浆水平几个数量级。此外,(前)肾素过表达动物的表型可以完全归因于血管紧张素的产生,甚至可能不需要受体。唯一可用的假定(前)肾素受体阻滞剂处理区域肽的疗效仍然值得怀疑,导致结果不确定。与其他 RAS 成分不同的事实是,(P)RR 敲除体,即使是组织特异性的,都是致命的,这表明(P)RR 具有重要的、(前)肾素独立的功能。事实上,最近的研究强调了(P)RR 的辅助功能,作为液泡型 H(+)-ATP 酶(V-ATPase)的必需辅助蛋白,并且在这种作用中,它作为 Wnt 信号的中间物起作用,而与(前)肾素无关。总之,(前)肾素依赖性信号转导在非(前)肾素合成器官中不太可能发生,(P)RR 在 V-ATPase 完整性和 Wnt 信号转导中的作用可能解释了以前与(前)肾素-(P)RR 相互作用相关的一些(如果不是全部)表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/a0a3de6cf548/424_2012_1105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/842f828d36dd/424_2012_1105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/726d4a5c3c42/424_2012_1105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/a0a3de6cf548/424_2012_1105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/842f828d36dd/424_2012_1105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/726d4a5c3c42/424_2012_1105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6af/3553411/a0a3de6cf548/424_2012_1105_Fig3_HTML.jpg

相似文献

1
The (pro)renin receptor. A decade of research: what have we learned?(原)肾素受体:十年研究,成果几何?
Pflugers Arch. 2013 Jan;465(1):87-97. doi: 10.1007/s00424-012-1105-z. Epub 2012 Apr 28.
2
HRP and prorenin: focus on the (pro)renin receptor and vacuolar H+-ATPase.辣根过氧化物酶与肾素原:聚焦于(前)肾素受体和液泡型H⁺-ATP酶
Front Biosci (Schol Ed). 2011 Jun 1;3(4):1205-15. doi: 10.2741/221.
3
(Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases?(Pro)肾素受体作为心血管疾病治疗的靶点?
Pharmacol Res. 2017 Nov;125(Pt A):48-56. doi: 10.1016/j.phrs.2017.05.016. Epub 2017 May 19.
4
(Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cells.原肾素受体是 MDCK.C11 集合管细胞中原肾素依赖性和非依赖性调控液泡 H ⁺ -ATP 酶活性所必需的。
Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F417-25. doi: 10.1152/ajprenal.00037.2013. Epub 2013 May 22.
5
Current knowledge of (pro)renin receptor as an accessory protein of vacuolar H+-ATPase.(原)肾素受体作为液泡 H+-ATP 酶辅助蛋白的现有知识。
J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):638-40. doi: 10.1177/1470320311429227.
6
Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.(前)肾素受体(Atp6ap2)在分子和系统水平上的功能:在高血压、肾脏和脑发育、炎症和纤维化中的病理意义。
Pharmacol Res. 2021 Nov;173:105922. doi: 10.1016/j.phrs.2021.105922. Epub 2021 Oct 2.
7
The Role of the (Pro)renin Receptor in Hypertensive Disease.(前)肾素受体在高血压疾病中的作用。
Am J Hypertens. 2015 Oct;28(10):1187-96. doi: 10.1093/ajh/hpv045. Epub 2015 Apr 18.
8
Biochemical properties of renin and prorenin binding to the (pro)renin receptor.肾素和原肾素与(前)肾素受体结合的生化特性。
Hypertens Res. 2010 Feb;33(2):91-7. doi: 10.1038/hr.2009.201. Epub 2009 Nov 27.
9
Prorenin receptor regulates more than the renin-angiotensin system.原啡啉受体调控的不仅仅是肾素-血管紧张素系统。
Ann Med. 2012 Jun;44 Suppl 1:S43-8. doi: 10.3109/07853890.2012.660496.
10
The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.(前)肾素受体作为心脏肾脏疾病的药理学靶点。
Hypertens Res. 2023 Nov;46(11):2527-2534. doi: 10.1038/s41440-023-01424-6. Epub 2023 Sep 4.

引用本文的文献

1
The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming.肾素-血管紧张素系统与心血管-肾脏-代谢综合征:关注生命早期编程。
Int J Mol Sci. 2024 Mar 14;25(6):3298. doi: 10.3390/ijms25063298.
2
Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy.阐明前肾素受体在胰腺导管腺癌进展中的作用:癌症治疗中的一个新的治疗靶点。
Curr Cancer Drug Targets. 2024;24(9):881-889. doi: 10.2174/0115680096279288231205105904.
3
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies.

本文引用的文献

1
Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.肾素和原肾素对人肾上腺皮质细胞系 H295R 和 HAC15 中的醛固酮合成没有直接影响。
J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):360-6. doi: 10.1177/1470320312438792. Epub 2012 Mar 6.
2
The prorenin receptor: what's in a name.肾素原受体:名字中有何深意。
J Am Soc Nephrol. 2011 Dec;22(12):2141-3. doi: 10.1681/ASN.2011100981. Epub 2011 Nov 3.
3
Prorenin receptor is essential for normal podocyte structure and function.
肾素-血管紧张素-醛固酮系统(RAAS)信号通路与癌症:对手还是盟友。
Cancer Cell Int. 2023 Oct 27;23(1):254. doi: 10.1186/s12935-023-03080-9.
4
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.血管功能和高血压中的信号通路:分子机制和治疗干预。
Signal Transduct Target Ther. 2023 Apr 20;8(1):168. doi: 10.1038/s41392-023-01430-7.
5
High-plasma soluble prorenin receptor is associated with vascular damage in male, but not female, mice fed a high-fat diet.高血浆可溶性肾素前体受体与高脂饮食喂养的雄性小鼠,而不是雌性小鼠的血管损伤有关。
Am J Physiol Heart Circ Physiol. 2023 Jun 1;324(6):H762-H775. doi: 10.1152/ajpheart.00638.2022. Epub 2023 Mar 17.
6
Potential of soluble (pro)renin receptor in kidney disease: can it go beyond a biomarker?可溶性(前)肾素受体在肾脏疾病中的潜力:它是否能超越生物标志物?
Am J Physiol Renal Physiol. 2022 Nov 1;323(5):F507-F514. doi: 10.1152/ajprenal.00202.2022. Epub 2022 Sep 8.
7
Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors.血管紧张素 II 通过不同的血管紧张素 II 受体作用对软骨细胞变性和保护的影响。
Int J Mol Sci. 2021 Aug 25;22(17):9204. doi: 10.3390/ijms22179204.
8
The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma.胶质母细胞瘤肿瘤微环境中的肾素-血管紧张素系统
Cancers (Basel). 2021 Aug 9;13(16):4004. doi: 10.3390/cancers13164004.
9
The (pro)renin receptor (ATP6ap2) facilitates receptor-mediated endocytosis and lysosomal function in the renal proximal tubule.(前)肾素受体(ATP6ap2)促进了肾近端小管中受体介导的内吞作用和溶酶体功能。
Pflugers Arch. 2021 Aug;473(8):1229-1246. doi: 10.1007/s00424-021-02598-z. Epub 2021 Jul 6.
10
Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins.针对肾素-血管紧张素-醛固酮系统预防发育起源性高血压和肾脏疾病。
Int J Mol Sci. 2021 Feb 25;22(5):2298. doi: 10.3390/ijms22052298.
原肾素受体对于正常足细胞的结构和功能至关重要。
J Am Soc Nephrol. 2011 Dec;22(12):2203-12. doi: 10.1681/ASN.2011020202. Epub 2011 Nov 3.
4
Prorenin receptor is essential for podocyte autophagy and survival.原朊素受体对于足细胞自噬和存活是必需的。
J Am Soc Nephrol. 2011 Dec;22(12):2193-202. doi: 10.1681/ASN.2011020200. Epub 2011 Oct 27.
5
Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?肾素和原肾素在人(pro)肾素受体过表达的大鼠血管平滑肌细胞中的作用:(pro)肾素-(pro)肾素受体相互作用真的发生了吗?
Hypertension. 2011 Dec;58(6):1111-9. doi: 10.1161/HYPERTENSIONAHA.111.180737. Epub 2011 Oct 24.
6
Detrimental effects of dual ACEI-ARB therapy: is the (pro)renin receptor the culprit?双重 ACEI-ARB 治疗的有害效应:(前)肾素受体是罪魁祸首吗?
Kidney Int. 2011 Nov;80(9):911-914. doi: 10.1038/ki.2011.264.
7
Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment.利用针对前肽 32-39 残基的单克隆抗体评估直接原肾素检测法。
J Hypertens. 2011 Nov;29(11):2138-46. doi: 10.1097/HJH.0b013e32834b1978.
8
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.经典 Wnt/β-连环蛋白信号通路介导转化生长因子-β1 诱导的足细胞损伤和蛋白尿。
Kidney Int. 2011 Dec;80(11):1159-1169. doi: 10.1038/ki.2011.255. Epub 2011 Aug 10.
9
Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.血管紧张素 II 阻断和肾素受体抑制联合应用可增强实验性肾炎的抗纤维化作用。
Am J Physiol Renal Physiol. 2011 Oct;301(4):F723-32. doi: 10.1152/ajprenal.00271.2011. Epub 2011 Jul 27.
10
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.血管紧张素转换酶抑制和受体阻断联合治疗与血液透析患者心血管死亡风险增加相关。
Kidney Int. 2011 Nov;80(9):978-985. doi: 10.1038/ki.2011.228. Epub 2011 Jul 20.